Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 35,499

Document Document Title
WO/2016/154447A1
A method to provide an inflated decellularized extracellular matrix of a mammalian organ or a vascularized portion thereof, or a mammalian vascularized tissue or a vascularized portion thereof, an inflated decellularized extracellular ma...  
WO/2016/153925A1
Various embodiments disclosed relate to melt-stabilized ultra high molecular weight polyethylene (UHMWPE), methods of making the same, and medical implants made from the same. In various embodiments, the present invention provides a meth...  
WO/2016/150876A1
The present invention shows a biphasic ceramic bone substitute comprising a resorbable calcium sulphate phase and a stable calcium phosphate phase acting as a bone graft and excellent carrier for a combination of bone active proteins (e....  
WO/2016/151133A1
The present invention relates to a method for preparing a skin substitute, to a method for preparing a dermal substitute, to a skin substitute, to a dermal substitute and to a kit for implementing the method. The present invention also r...  
WO/2016/154063A1
An engineered medical device for treatment of osteonecrosis is provided where the size, porosity and ceramic content of the device can be personalized based on an individual patient's anatomical and physiological condition. The device di...  
WO/2016/154452A3
Disclosed are compositions comprising a meniscal tissue. For example, disclosed are compositions comprising a meniscal tissue, wherein the meniscal tissue comprises one or more engineered channels. Disclosed are compositions comprising a...  
WO/2016/153534A1
Bioremodelable tissue prostheses having a vasculature that is infused with a biomaterial composition. The present invention is directed to casted constructs for treating, reconstructing or replacing damaged or diseased biological tissue....  
WO/2016/153925A8
Various embodiments disclosed relate to melt-stabilized ultra high molecular weight polyethylene (UHMWPE), methods of making the same, and medical implants made from the same. In various embodiments, the present invention provides a meth...  
WO/2016/153320A1
Provided are a method for manufacturing a three-dimensional structure for cardiac muscular tissue regeneration, and a three-dimensional structure for cardiac muscular tissue regeneration, the method comprising the steps of: forming a thr...  
WO/2016/153179A1
The present invention provides a composition for three-dimensional printing, containing: a decellularized extracellular matrix; and riboflavin as a cross-linking agent. A three-dimensional structure having high mechanical strength can be...  
WO/2016/154289A1
The present application draws attention to particulate materials derived from carbonaceous materials, such as carbon foam, as a platform technology for multiple medical procedures performed to address diverse tissue deficits and/or patho...  
WO/2016/149615A1
Disclosed herein are polypeptides comprising an amino acid sequence of {[VPGVG]4IPGVG}n, wherein n is an integer greater than 1. The polypeptides can be crosslinked to from biocompatible hydrogels with tunable and desirable mechanical pr...  
WO/2016/149673A1
Microneedle arrays and methods of forming the same can include one or more bioactive components bonded to a biocompatible material such that the one or more bioactive components are cleavable in vivo to release the bioactive component fr...  
WO/2016/148172A1
The present invention addresses: the problem of producing a high-purity magnesium material that has almost the same strength as those of implants each made from titanium or a titanium alloy, which have been used generally due to their st...  
WO/2016/148245A1
The present invention addresses the problem of providing a cartilage-regenerating material which makes it possible to regenerate a bone and a cartilage using cells. According to the present invention, a cartilage-regenerating material is...  
WO/2016/146954A1
The present invention relates to the preparation of injectable collagen suspensions, to the method for preparing said suspensions, and to the uses thereof, particularly for forming dense collagen matrices.  
WO/2016/148246A1
The present invention addresses the problem of providing a cartilage regeneration material for suppressing fibrous soft tissue infiltration and providing good cartilage regeneration, and a method for producing this cartilage regeneration...  
WO/2016/145957A1
A corrosion-resistant, high strength and ductility Zn-Fe zinc alloy degradable by the human body and applications of the alloy. The zinc alloy comprises elements Zn and Fe, where the mass percentage of element Zn is: 90-99.998%, and the ...  
WO/2016/149194A1
Compositions containing purified collagen biomaterial derived from tissues, for example, insoluble amnion, soluble amnion, soluble chorion of the human placenta, are provided. The collagen compositions can be used to promote wound healin...  
WO/2016/148958A1
The present disclosure is directed to methods, compositions, devices and kits which pertain to the attachment of surgical meshes to tissue by application of an energy source to the meshes and tissue in the presence of a bonding material.  
WO/2016/145956A1
A corrosion-resistant, high strength and ductility Zn-Fe-X zinc alloy and applications thereof in medical implant materials. The zinc alloy comprises elements Zn, Fe, and X, where the element X is at least one among Mg, Ca, and Sr, the m...  
WO/2016/145955A1
A corrosion-resistant, high strength and ductility Zn-Fe-Re zinc alloy degradable by the human body and applications of the alloy. The zinc alloy comprises elements Zn, Fe, and RE, where the mass percentage of element Zn is: 82-99.997%, ...  
WO/2016/144096A1
The present invention relates to a stent having a functional material coated on a cell space (safe coating space) thereof. The stent of the present invention, as a stent having a space for mounting and coating drugs and other materials f...  
WO/2016/144182A1
The invention is directed to biocompatible composite materials for medical applications such as tissue regeneration. In particular, the present invention is directed to biocompatible composite materials that may be used for the treatment...  
WO/2016/142401A1
The invention concerns a method of forming a medical device, the method comprising: forming a graphene film (100) over a substrate (204); depositing, by gas phase deposition, a polymer material covering a surface of the graphene film (10...  
WO/2016/142617A1
According to the invention, said tissue endoprosthesis comprises an expandable support structure or stent (2) held between an inner tissue structure (4) and an outer coating (10) consisting of a hemocompatible soft synthetic material whi...  
WO/2016/142949A1
A prosthetic implant with improved properties, suitable for implantation to the human body, comprising a composite comprising a base material and a plurality of additives, wherein the additives are selected from radiolucent additives and...  
WO/2016/142703A1
The invention provides biocompatible implants ("scaffolds") for use in the treatment of tendon injury and/or modulation of the biomechanical properties of tendon. More particularly, the invention provides biocompatible implants capable o...  
WO/2016/143647A1
[Problem] To provide a gel which can be produced in a short time, has controlled properties such as modulus and expansion pressure, and has a low polymer concentration. [Solution] A process for producing a polymer gel in which gel-precur...  
WO/2016/144166A1
The invention is directed to a nerve cap for covering a nerve stump, comprising a tubular body with a closed end and an open end and essentially consisting of biodegradable polymeric material to prevent or treat symptoms caused by neurom...  
WO/2016/139593A1
A method of providing a polymer element with enhanced radio-opacity, comprising providing a treatment fluid comprising an oil-based fluid having a contrast agent, and bringing the polymer element and treatment fluid into contact such tha...  
WO/2016/141242A1
Provided are compositions and methods for a scaffold coated with a primer coating and a mineral coating. Also provided is a composition for a scaffold having a mineral coating similar to bone. Also provided is a method for mineral coatin...  
WO/2016/141137A1
Methods of tissue engineering, and more particularly methods and compositions for generating various vascularized 3D tissues, such as 3D vascularized embryoid bodies and organoids are described. Certain embodiments relate to a method of ...  
WO/2016/138701A1
An artificial blood vessel and a preparation method thereof, relating to the fields of organ manufacturing and biological materials. The artificial blood vessel comprises an outer skin layer, a fibroblast layer, a smooth muscle cell laye...  
WO/2016/140369A1
The purpose of the present invention is to provide a cellulose structure having novel characteristics. Specifically, the present invention pertains to synthesizing a cellulose three-dimensional structure having novel characteristics by u...  
WO/2016/138702A1
A fully functional artificial organ pseudo-body and a preparation and culturing method thereof, relating to the interdisciplinary fields of biology, materials, and manufacturing. The pseudo-body comprises an outer skin layer (101) and an...  
WO/2016/140626A1
The present disclosure describes a composite material for delivering an active ingredient, the composite material comprising a substantially homogeneous mixture of a biodegradable polyester; a ceramic; and a porogen. In particular, said ...  
WO/2016/134819A1
The invention relates to a material for bone implants, comprising: a surface consisting of oxide ceramic materials, titanium or polyether ether ketone (PEEK) or other polymer or composite materials; a matrix which consists of collagen or...  
WO/2016/137327A1
The invention is directed to a multilayered drug eluting biodegradable foam comprising at least two layers, wherein each layer independently comprises a polymer and wherein at least one of said layers is a drug-comprising layer, which co...  
WO/2016/134626A1
A method for preparing a three-dimensional interconnected porous magnesium-based material and a use thereof. The preparation method comprises: preparing a porous titanium preform or a porous iron preform; filling a magnesium-based molten...  
WO/2016/136886A1
Provided is a medical/cosmetic material in which characteristics inherent in polyanionic polysaccharides, which are starting materials, are maintained, that is highly safe because there is no need to use chemical cross-linking agents dur...  
WO/2016/136633A1
The present invention addresses the problem of providing a decellularized tissue having excellent cell adhesion properties. Provided is a decellularized tissue prepared by decellularizing a biological tissue, said decellularized tissue b...  
WO/2016/138416A1
Provided herein is a mandrel for use in electrospinning prosthetic valve devices. Also provided are prosthetic valve devices for implantation in an animal or a human. Methods of making and using the valve devices are also provided herein.  
WO/2016/135194A1
In order to check a material for transplantation, at least one Raman spectrum (41, 42) of the material is detected. An electronic evaluation device determines an information, from which depends a suitability of the material for use durin...  
WO/2016/136884A1
Provided is a medical material in which the properties inherent in a polyanionic polysaccharide, which is the raw material, are retained, said medical material having a high stability because the use of a chemical crosslinking agent is n...  
WO/2016/134866A1
The invention relates to a method for producing an implant which is in particular in the form of a wound dressing. The implant consists of a magnesium sheet material embedded in a collagen nonwoven.  
WO/2016/134409A1
The invention relates to the incorporation of bone-growth reactive compounds and anti-infection agents upon the surface of an implantable polymeric material to enhance the biological properties of the resultant multifunctional composite ...  
WO/2016/135349A1
Phase segregated block-copolymer based on repeating structural elements represented by formula (I) wherein PHA represents at least one block based on one or more a-hydroxy acids, PDAS represents a central block based on a dialkylsiloxane...  
WO/2016/133656A1
Intraocular lens materials are disclosed. They are are soft and very deformable and have a high refractive index, and a high glistening resistance in fully hydrated state. They are particularly suitable for making wet-packed intraocular ...  
WO/2016/131796A1
The invention relates to an ophthalmological composition with at least one molecular switch connection, which can be switched between a first state and a second state by means of a stimulus, wherein the molecular switch connection has di...  

Matches 551 - 600 out of 35,499